INVESTIGADORES
LOZANO Mario Enrique
congresos y reuniones científicas
Título:
Sources of genetic variation in arenaviridae - theoretical models and evidence in nature
Autor/es:
GHIRINGHELLI, P.D.; GOÑI, S.E.; LOZANO, M.E.; POSIK, D.M.; ROMANOWSKI, V.
Lugar:
Paris
Reunión:
Congreso; XIIth International Congress of Virology, International Union of Microbiological Societies; 2002
Institución organizadora:
International Union of Microbiological Societies
Resumen:
Arenaviruses have a bipartite ssRNA genome
with an ambisense coding strategy. The virions are enveloped and package
non-equimolar amounts of each genomic RNA species (L and S RNAs). Genetic reassortment in dually infected cells
has been recognized as a major source for genetic variation; more recently,
evidence has emerged that suggests the possibility of RNA recombination.
Some arenaviruses have been recognized as
etiological agents for serious human diseases. The common feature of these
diseases is their restricted geographical distribution and the emerging
character of the first outbreaks. The
main causes for the emergence of new viral diseases include changes in the
ecology, human activity and viral genome variation.
Here we present alternative models for
molecular recombination based upon the analysis of previously reported and
recently obtained arenavirus RNA sequences. The molecular mechanisms that lead
to the formation of recombinant RNA species may include template-switching,
primer-alignment-and-extension and transesterification. Whitewater Arroyo (isolated in the US) and
Rio Carcarañá Virus (recently isolated in Argentina) provide evidence for RNA
recombination between New World Arenaviruses of different lineages in nature.
This and other genetic variation
mechanisms, as well as the use of sensitive detection and analysis methods,
indicate that the number of members of the Arenaviridae
will probably continue to grow. Finally, it is possible to speculate that
emergence or re-emergence of human infections could be minimized with the help
of careful molecular-epidemiological surveillance programs.